Financials in USD. Standardized financial statements.
A compact view of how BioLargo, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $7.76M | $17.78M | $12.23M | $5.88M | $2.53M | $2.43M | $1.86M | $1.36M | $516,213 | $281,106 |
| Revenue Growth? | -56.3% | +45.4% | +107.9% | +132.5% | +4.1% | +30.7% | +36.4% | +164.2% | +83.6% | 0.0% |
| Cost of Revenue? | $4.36M | $9.93M | $6.08M | $3.03M | $1.43M | $1.20M | $945,000 | $743,000 | $322,717 | $105,877 |
| Gross Profit? | $3.41M | $7.85M | $6.15M | $2.86M | $1.10M | $1.23M | $916,000 | $621,000 | $193,496 | $175,229 |
| Gross Margin? | +43.9% | +44.2% | +50.3% | +48.6% | +43.6% | +50.5% | +49.2% | +45.5% | +37.5% | +62.3% |
| Operating Expenses? | $18.25M | $12.18M | $10.34M | $7.98M | $7.48M | $8.67M | $7.39M | $6.88M | $6.09M | $5.11M |
| Operating Income? | -$14.84M | -$4.33M | -$4.19M | -$5.12M | -$6.38M | -$7.45M | -$6.48M | -$6.41M | -$5.90M | -$4.93M |
| EBITDA? | -$14.55M | -$4.06M | -$4.19M | -$5.10M | -$6.70M | -$7.83M | -$7.44M | -$7.22M | -$5.73M | -$4.93M |
| Income Before Tax | -$15.19M | -$2.40M | -$4.63M | -$5.13M | -$6.89M | -$9.70M | -$11.44M | -$10.70M | -$9.55M | -$8.07M |
| Income Tax Expense | $0 | $1.95M | $13,000 | $0 | $0 | $0 | $0 | $0 | $3.43M | $0 |
| Net Income? | -$11.78M | -$2.40M | -$3.50M | -$4.50M | -$7.38M | -$10.47M | -$14.75M | -$10.22M | -$9.12M | -$7.84M |
| EPS? | $-0.04 | $-0.01 | $-0.01 | $-0.02 | $-0.03 | $-0.05 | $-0.10 | $-0.08 | $-0.09 | $-0.09 |
| Diluted EPS? | $-0.04 | $-0.01 | $-0.01 | $-0.02 | $-0.03 | $-0.05 | $-0.10 | $-0.08 | $-0.09 | $-0.09 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality